Top compounds associated with response to OR14A2


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:GDC-0941 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.049 0.2
mRNA linifanib CTRPv2 pan-cancer AAC -0.048 0.2
mRNA Gemcitabine CTRPv2 pan-cancer AAC 0.046 0.2
mRNA JQ-1 CTRPv2 pan-cancer AAC -0.043 0.2
mRNA ciclosporin CTRPv2 pan-cancer AAC -0.051 0.2
mRNA ciclopirox CTRPv2 pan-cancer AAC -0.044 0.2
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.047 0.2
mRNA vincristine CTRPv2 pan-cancer AAC 0.041 0.2
mRNA navitoclax:PLX-4032 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.047 0.2
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.049 0.2
Download CSV